NewsSource: EClinCloud

EClinCloud Product Overview | IRC · Independent Central Imaging Assessment Solution

3 min readEClinCloud Editorial Team
EClinCloud Product Introduction | IRC · Independent Central Imaging Assessment Solution header image

Source: EClinCloud. Author: EClinCloud.

EClinCloud · Clinical Research AI Technology Company

IRC · Independent Central Imaging Assessment Solution

One-Stop Solution · Senior Specialists Across Multiple Therapeutic Areas

Through an independent, blinded, and standardized reading mechanism, IRC provides objective and consistent imaging endpoint assessment results for trials, making it an important part of ensuring study endpoint reliability and regulatory acceptance.

EClinCloud IRC provides a proprietary intelligent reading system, senior specialists across multiple therapeutic areas, and end-to-end medical team services to help sponsors achieve more standardized and traceable independent central imaging assessment.

01  Product Overview

The EClinCloud IRC (Independent Review Committee) system integrates image upload and image reading technologies through advanced technology and platform capabilities to provide clinical trial sites and multicenter studies with a standardized integrated independent reading management platform that meets GxP requirements. Combining an IRC service team spanning multiple therapeutic areas (including oncology, central nervous system, and ophthalmology, among others) with extensive reading specialist resources, EClinCloud provides reliable endpoint solutions for clinical trials.

02  What We Offer

■ Third-Party Independent Assessment System and Configuration Services

■ Independent Review Committee and Independent Reader Management Services

■ Independent Medical Imaging Reading Services

■ Endpoint Adjudication Committee Management Services

03  Why Choose EClinCloud IRC

■ Proprietary reading system integrating image upload and image reading platforms

■ End-to-end follow-up by a medical team to ensure reading timeliness and project quality

■ Experienced core team covering multiple oncology and non-oncology indications

■ Extensive network of senior specialists across multiple therapeutic areas delivering more specialized reading services

■ Reading system and independent reading service solutions across multiple therapeutic areas, including oncology and non-oncology (ophthalmology, central nervous system, cardiovascular, dermatology, respiratory, and endocrinology)

04  Value Proven in Client Practice

Case Study: Supporting Efficient, High-Quality Execution of a Cardiovascular Project

Cardiovascular clinical research involves multimodal imaging endpoint assessment, placing high demands on consistency of reading standards, data quality, image acquisition, and reading evaluation. EClinCloud achieves end-to-end controllable progress and traceable deliverables, providing standardized support for the measurement of over 30 cardiovascular parameters across multiple techniques including echocardiography and cardiac MRI, comprehensively supporting efficient advancement and high-quality delivery of cardiovascular clinical research projects.

6 weeks to complete deployment efficiently  |  30 parameter measurements meeting standardization requirements

Integrated Platform · Data Interconnectivity

IRC CTMS eTMF eCOA RTSM RM EDC eLearning Scale Management Rater Training

📞 Contact Us

Website: www.eclincloud.com

Email: ecc@eclincloud.com

Technological innovation to bring effective treatments to patients




About EClinCloud


EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it develops an integrated clinical intelligence cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient, precise digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug/device development cycles to benefit patients.







Article illustration

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.